Cambridge Investment Research Advisors’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDT
CIA
CAI
HPC
Cambridge Investment Research Advisors's IBDT Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 0.49% in Q2 2026, selling an estimated $29.8K and leaving 240,359 shares worth $6.07M. The position accounts for 0.01% of the portfolio, ranked #913.
Cambridge Investment Research Advisors first reported a position in IBDT in Q3 2019 and has held it in 24 quarters since. The position peaked at $6.12M in Q1 2026. 435 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.
- Cambridge Investment Research Advisors held 240,359 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $6.07M as of Q2 2026.
- Cambridge Investment Research Advisors sold 1,179 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $29.8K.
- iShares iBonds Dec 2028 Term Corporate ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #913 holding.
- Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q3 2019 and has held it in 24 quarters since.
- Cambridge Investment Research Advisors's iShares iBonds Dec 2028 Term Corporate ETF position peaked at $6.12M in Q1 2026.
- 435 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.